Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome

Adv Neurol. 1995:65:259-72.

Abstract

As in many other areas of science, improvements in research methodologies lead the way to powerful new understanding of disorders and their treatment. Great strides have been made in defining the phenomenology of TS and its relationship to other disorders. However, we have not yet reached a true consensus and developed treatment strategies based on that consensus. Clearly much research needs to be done. Identifying the putative gene for TS would greatly accelerate this process.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / etiology*
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Child
  • Child Behavior Disorders / etiology
  • Child Behavior Disorders / psychology
  • Clonidine / therapeutic use
  • Comorbidity
  • Dextroamphetamine / therapeutic use
  • Guanfacine / therapeutic use
  • Humans
  • Learning Disabilities / etiology
  • Learning Disabilities / psychology
  • Methylphenidate / therapeutic use
  • Pemoline / therapeutic use
  • Selegiline / therapeutic use
  • Tourette Syndrome / complications*
  • Tourette Syndrome / epidemiology
  • Tourette Syndrome / psychology

Substances

  • Antidepressive Agents, Tricyclic
  • Methylphenidate
  • Selegiline
  • Guanfacine
  • Pemoline
  • Clonidine
  • Dextroamphetamine